Zobrazeno 1 - 10
of 13
pro vyhledávání: '"H. D. H. Showalter"'
Publikováno v:
Diabetes, Obesity and Metabolism. 13:434-438
Aim: To assess the safety, tolerability, pharmacokinetics, pharmacodynamics and potential immunogenicity of single, escalating subcutaneous injections of a once-weekly glucagon-like peptide-1 analogue in healthy subjects. Methods: This phase 1, three
Autor:
Thomas Hardy, S. Cui, F. Tibaldi, B. Ellis, H. D. H. Showalter, P. Barrington, K. Schneck, Jenny Y. Chien
Publikováno v:
Diabetes, Obesity and Metabolism. 13:426-433
Aim: To investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of LY2189265 (LY), a novel, long-acting glucagen-like peptide-1 analogue, administered once weekly to subjects with type 2 diabetes. Methods: This was a placebo-contr
Autor:
Jeffrey Bruce Smaill, Brian D. Palmer, Alexander James Bridges, Bill J. Roberts, James M. Nelson, David W. Fry, Ellen M. Dobrusin, Gordon W. Rewcastle, R. T. Winters, W. L. Elliot, H. D. H. Showalter, S. J. Patmore, Patrick W. Vincent, William A. Denny, Zhou Hairong, W. R. Leopold, Dennis J. McNamara, V. Slintak
Publikováno v:
Journal of medicinal chemistry. 42(10)
A series of 6- and 7-acrylamide derivatives of the 4-(phenylamino)quinazoline and -pyridopyrimidine classes of epidermal growth factor receptor (EGFR) inhibitors were prepared from the corresponding amino compounds by reaction with either acryloyl ch
Autor:
William A. Denny, Jeffrey Bruce Smaill, AM Doherty, James M. Hamby, Alan J. Kraker, Brian D. Palmer, TK Dahring, JB Kramer, DH Boschelli, Khatana Ss, Maruta Boyd, Robert L. Panek, R. T. Winters, Gina H. Lu, H. D. H. Showalter
Publikováno v:
Journal of medicinal chemistry. 41(27)
1-Phenylbenzimidazoles are shown to be a new class of ATP-site inhibitors of the platelet-derived growth factor receptor (PDGFR). Structure-activity relationships (SARs) are narrow, with closely related heterocycles being inactive. A systematic study
Autor:
James M. Nelson, Gordon W. Rewcastle, D. K. Murray, Patrick W. Vincent, Curtis T. Howard, H. D. H. Showalter, William A. Denny, Bill J. Roberts, William L. Elliott, R. T. Winters, David W. Fry
Publikováno v:
Journal of medicinal chemistry. 41(5)
The 4-[(3-bromophenyl)amino]pyrido[3,4-d]pyrimidine PD 158780 is a very potent in vitro inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) (IC50 0.08 nM), and other members of the erbB family, by competitive bind
Publikováno v:
Chemischer Informationsdienst. 15
Publikováno v:
Chemischer Informationsdienst. 13
Publikováno v:
Chemischer Informationsdienst. 14
Publikováno v:
Chemischer Informationsdienst. 9
Autor:
H. D. H. SHOWALTER, T. H. HASKELL
Publikováno v:
Chemischer Informationsdienst. 12